Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique

Virchows Archiv

Volumn 445, Issue 6, 2004, Pages 631-636

  Langner, Cord ^a   Von Wasielewski, Reinhard ^b   Ratschek, Manfred ^a   Rehak, Peter ^a   Zigeuner, Richard ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

p27; Prognosis; Renal cell carcinoma; Skp2; Tissue microarray

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CLEAR CELL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; KIDNEY METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; S-PHASE KINASE-ASSOCIATED PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 12144265822     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1121-2     Document Type: Article

References (30)

1. Ben-Izhak O, Lahaz-Baratz S, Meretyk S, Ben-Eliezer S, Sabo E, Dirnfeld M, Cohen S, Ciechanover A (2003) Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27kip1 in prostate cancer. J Urol 170:241-245
2. Carrano AC, Pagano M (2001) Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol 153:1381-1389
3. Carrano AC, Eytan E, Hershko A, Pagano M (1999) Skp2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199
4. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparison of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612-624
5. Chiarle R, Fan Y, Piva R, Boggino H, Skolnik J, Novero D, Palestro G, De Wolf-Peeters C, Chilosi M, Pagano M, Inghirami G (2002) S-phase kinase-associated protein 2 expression in non-Hodgkin' lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol 160:1457-1466
6. Eble JN, Togashi K, Pisani P (2004) Renal cell carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of tumours. Pathology & genetics, tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 12-43
7. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663
8. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, Krek W (2001) Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A 98:5043-5048
9. Haitel A, Wiener HG, Neudert B, Marberger M, Susani M (2001) Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urology 58:477-481
10. Hara T, Kamura T, Nakayama K, Oshikawa K, Hatekeyama S, Nakayama K (2001) Degradation of p27kip1 at the G0-G1 transition mediated by a skp2-independent ubiquitination pathway. J Biol Chem 276:48937-48943
11. Hedberg Y, Davoodi E, Ljungberg B, Roos G, Landberg G (2002) Cyclin E and p27 protein content in human renal cell carcinoma: Clinical outcome and associations with cyclin D. Int J Cancer 102:601-607
12. Hedberg Y, Ljungberg B, Roos G, Landberg G (2003) Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 88:1417-1423
13. Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, Hershko A (2001) Inverse relation between levels of p27kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer 91:1745-1751
14. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847
15. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T (2001) High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 61:7044-7047
16. Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G, Pagamo M (2001) Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci U S A 98:2515-2520
17. Lim MS, Adamson A, Lin Z, Perez-Ordonez B, Jordan RC, Tripp S, Perkins SL, Elenitoba-Johnson KS (2002) Expression of Skp2, a p27 (Kip1) ubiqitin ligase, in malignant lymphoma: correlation with p27 (Kip1) and proliferation index. Blood 100:2950-2956
18. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW (1999) p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154:313-323
19. Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama T, Nakayama T, Mori M (2002) Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 62:3819-3825
20. McKay JA, Douglas JJ, Ross VG, Curran S, Ahmed FY, Loane JF, Murray GI, McLeod HL (2000) Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin Cancer Res 6:1113-1118
21. McLaughlin JK, Lipworth L (2000) Epidemiologic aspects of renal cell cancer. Semin Oncol 27:115-123
22. Méjean A, Oudard S, Thiounn N (2003) Prognostic factors of renal cell carcinoma. J Urol 169:821-827
23. Migita T, Oda Y, Naito S, Tsuneyoshi M (2002) Low expression of p27kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 94:973-979
24. Oliveira AM, Okuno SH, Nascimento AG, Lloyd RV (2003) Skp2 protein expression in soft tissue sarcomas. J Clin Oncol 21:722-727
25. Shigemasa K, Gu L, O'Brien TJ, Ohama K (2003) Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 9:1756-1763
26. Shirane M, Harumiya Y, Ishida N, Hirai A, Miyamoto C, Hatakeyama S, Nakayama K, Kitagawa M (1999) Down-regulation of p27kip1 by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274:13886-13893
27. Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, Monti F, Loda M, Pagano M (2002) Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest 110:633-641
28. Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, Inc., New York
29. Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler TM, Thompson TC, Harper JW (2002) Elevated Skp2 protein expression in human prostate cancer: association with loss of cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res 8:3419-3426
30. Yokoi S, Yasui K, Mori M, Iizasa T, Fujisawa T, Inazawa J (2004) Amplification and overexpression of Skp2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Am J Pathol 165:175-180